<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03062748</url>
  </required_header>
  <id_info>
    <org_study_id>5218</org_study_id>
    <nct_id>NCT03062748</nct_id>
  </id_info>
  <brief_title>Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index</brief_title>
  <official_title>Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the relative contribution of systemic inflammation vs.
      Obstructive Sleep Apnea (OSA) severity (as measured by Apnea Hypopnea Index) in predicting
      cardiovascular and metabolic aberrations associated with mild-to-moderate obstructive sleep
      apnea.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of the metabolic syndrome</measure>
    <time_frame>baseline</time_frame>
    <description>At least 3 of the following 5 risk factors must be met in order to have the metabolic syndrome:
Elevated waist measurement (≥102 cm for men or ≥89 cm for women)
Elevated triglycerides (≥150 mg/dL or use of medication)
Low HDL cholesterol (&lt;50 mg/dL for women or &lt;40 mg/dL for men or use of medication)
Elevated blood pressure (≥130 mmHg systolic or ≥ 85 mmHg diastolic or use of medication)
Elevated fasting blood sugar (≥100 mg/dL or use of medication)
Source: https://www.nhlbi.nih.gov/health/health-topics/topics/ms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Obstructive Sleep Apnea</measure>
    <time_frame>baseline</time_frame>
    <description>AHI from one night polysomnography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Markers of systemic inflammation</measure>
    <time_frame>baseline</time_frame>
    <description>CRP, IL-6, TNFa</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>baseline</time_frame>
    <description>from polysomnography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective measure of sleepiness</measure>
    <time_frame>baseline</time_frame>
    <description>Epworth Sleepiness Scale</description>
  </secondary_outcome>
  <enrollment type="Anticipated">196</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspected OS who are being seen at the Sleep Research and Treatment Center.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mild to moderate OSA (5≤ AHI &lt;30)

          -  BMI ≤ 45

          -  Age ≥ 18

          -  Men &amp; Women

        Exclusion Criteria:

          -  AHI ≥ 30

          -  BMI &gt;45

          -  Current use of steroids or anti-inflammatory medication

          -  Diagnosis of insulin dependent diabetes

          -  Diagnosis of autoimmune disorder

          -  Shiftwork

          -  Current use of CPAP
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Penn State College of Medicine, Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2017</study_first_submitted>
  <study_first_submitted_qc>February 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Alexandros Vgontzas</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

